Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Read more about Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
Hematopoietic cell transplantation for Chediak-Higashi syndrome. Read more about Hematopoietic cell transplantation for Chediak-Higashi syndrome.
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. Read more about Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus. Read more about Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus.
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML. Read more about Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.
Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Read more about Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Read more about Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Read more about Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children. Read more about Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children.
Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection post-transplant. Read more about Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection post-transplant.
